StockData
Eikon Therapeutics, Inc. logo

Eikon Therapeutics, Inc. (EIKN) stock

EIKNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$5.17+0.02 (+0.39%)

Close on Nov 18, 2026Market cap $280.03MP/E –Yield –

Eikon Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Eikon Therapeutics's market cap was $361.17M on Nov 11, 2026.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$361.17M–

More Eikon Therapeutics figures

See a number that looks wrong?